Home > Annual Financials > SENORES PHARMACEUTICALS

SENORES PHARMACEUTICALS Financial Statement Analysis
[BOM: 544319|NSE : SENORES]

The Revenues of SENORES PHARMACEUTICALS have increased by 85.65% YoY .
The Earnings Per Share (EPS) of SENORES PHARMACEUTICALS has increased by 23.38 % YoY.
COMMUNITY POLL
for SENORES PHARMACEUTICALS
Please provide your vote to see the results

SENORES PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 544319|NSE : SENORES]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Revenues ₹398 Cr₹215 Cr₹35 Cr₹14 Cr
Expenses ₹309 Cr₹173 Cr₹23 Cr₹12 Cr
Operating Profit (Excl OI) ₹90 Cr₹42 Cr₹13 Cr₹1.95 Cr
Other Income ₹19 Cr₹2.82 Cr₹3.68 Cr₹0.46 Cr
Interest ₹22 Cr₹9.45 Cr₹2.14 Cr₹0.57 Cr
Depreciation ₹17 Cr₹10.00 Cr₹1.78 Cr₹0.71 Cr
Profit Before Tax ₹71 Cr₹25 Cr₹12 Cr₹1.14 Cr
Profit After Tax ₹58 Cr₹33 Cr₹8.43 Cr₹0.99 Cr
Consolidated Net Profit ₹59 Cr₹31 Cr₹8.43 Cr₹0.99 Cr
Earnings Per Share (Rs)₹12.72₹10.31₹8.59₹1.13
PAT Margin (%)14.6515.2523.866.99
ROE(%)11.7826.1920.552.71
ROCE(%)11.9412.3118.563.36
Total Debt/Equity(x)0.391.221.340.39

Key Financials

Market Cap : ₹ 6,390.2 Cr
Revenue (TTM) : ₹ 649.5 Cr
Net Profit(TTM) : ₹ 121.6 Cr
EPS (TTM) : ₹ 26.4
P/E (TTM) : 52.6

Industry Peers & Returns1W1M1Y
SENORES PHARMACEUTICALS 0% 8.6% 124.5%
SUN PHARMACEUTICAL INDUSTRIES -0.8% 3.5% 14.7%
DIVIS LABORATORIES -1% 7.3% 7.6%
TORRENT PHARMACEUTICALS -0.9% 10.1% 44.6%
CIPLA -2.1% -1.8% -6%
DR REDDYS LABORATORIES -5.8% -13.2% -7.7%
MANKIND PHARMA -2.4% 1.2% -3.2%
LUPIN -4.4% 0.1% 22.5%
ZYDUS LIFESCIENCES -3.3% 0.9% 13.4%


SENORES PHARMACEUTICALS Revenues
[BOM: 544319|NSE : SENORES]

Y-o-Y

85.65 %

5 Yr CAGR

204.04 %

Years Revenues % Change
Mar2025 ₹398 Cr
85.65
Mar2024 ₹215 Cr
507.07
Mar2023 ₹35 Cr
149.38
Mar2022 ₹14 Cr -


SENORES PHARMACEUTICALS Operating Profit
[BOM: 544319|NSE : SENORES]

Y-o-Y

115.61 %

5 Yr CAGR

258.09 %

Years Operating Profit % Change
Mar2025 ₹90 Cr
115.61
Mar2024 ₹42 Cr
228.10
Mar2023 ₹13 Cr
549.08
Mar2022 ₹1.95 Cr -

Operating Margins
Y-o-Y

16.15 %

5 Yr CAGR

17.77 %

Years Operating Margin% % Change
Mar2025 22.51%
16.15
Mar2024 19.38%
-45.94
Mar2023 35.85%
160.16
Mar2022 13.78% -

SENORES PHARMACEUTICALS Profit After Tax
[BOM: 544319|NSE : SENORES]

Y-o-Y

86.14 %

5 Yr CAGR

289.50 %

Years Profit After Tax % Change
Mar2025 ₹59 Cr
86.14
Mar2024 ₹31 Cr
273.06
Mar2023 ₹8.43 Cr
750.96
Mar2022 ₹0.99 Cr -

PAT Margins
Y-o-Y

-3.93 %

5 Yr CAGR

27.97 %

Years PAT Margin(%) % Change
Mar2025 14.65 %
-3.93
Mar2024 15.25 %
-36.09
Mar2023 23.86 %
241.34
Mar2022 6.99 % -

SENORES PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 544319|NSE : SENORES]

Y-o-Y

23.38 %

5 Yr CAGR

124.11 %

Years EPS % Change
Mar2025 ₹13
23.38
Mar2024 ₹10
20.02
Mar2023 ₹8.59
660.18
Mar2022 ₹1.13 -

SENORES PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 544319|NSE : SENORES]

Y-o-Y

-3.01 %

5 Yr CAGR

52.60 %

Years ROCE % Change
Mar2025 11.94%
-3.01
Mar2024 12.31%
-33.67
Mar2023 18.56%
452.38
Mar2022 3.36% -

SENORES PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹1,386.2
Current MarketCap: ₹ 6,390.2 Cr
Updated EOD on :Jul 24,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
SENORES PHARMACEUTICALS

0%

8.6%

124.5%

SENSEX

-2.7%

-0.2%

-8%

SENORES PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE -0.8% 1.8% 9.1%
No NSE index found

You may also like the below Video Courses


FAQ about SENORES PHARMACEUTICALS Financials


How the annual revenues of SENORES PHARMACEUTICALS have changed ?

The Revenues of SENORES PHARMACEUTICALS have increased by 85.65% YoY .

How the Earnings per Share (EPS) of SENORES PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of SENORES PHARMACEUTICALS has increased by 23.38 % YoY .